110,180.00
-11,540.00
(-9.48%)
As of 1:36:01 PM GMT-3. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 17 | 22 | 20 |
| Avg. Estimate | 1.94B | 2.01B | 8.1B | 8.97B |
| Low Estimate | 1.93B | 1.97B | 7.93B | 8.56B |
| High Estimate | 2.09B | 2.16B | 8.52B | 9.77B |
| Year Ago Sales | 1.82B | 1.88B | 7.43B | 8.1B |
| Sales Growth (year/est) | 6.63% | 6.78% | 9.03% | 10.73% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HWMCL.SN | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 2/19/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/18/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/18/2025 |
| Reiterates | Truist Securities: Buy to Buy | 2/14/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 2/14/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/14/2025 |